Menu

Leap Therapeutics, Inc. LPTX

Full chart Compare
Set alert

Price alert · LPTX

All alert types
0.77 0.00 (+0.00%)

Apr 1, 2026, 9:30 AM EDT

0.7351 Day range 0.7971

52-week range unavailable

YTD
-73.28%
1 year
-76.32%

Revenue & Expenses

Other Income → Expenses: $856.00KIncome Tax Benefit → Expenses: $24.00KExpenses → Selling, General & Admin: $10.77MExpenses → Research & Development: $32.16MExpenses → Interest Expense: $41.00KGross Profit → Expenses: $1.50MRevenue → Gross Profit: $1.50MNet Loss → Expenses: $40.59MOther Income$856.00KIncome Tax Benefit$24.00KGross Profit$1.50MNet Loss$40.59MExpenses$42.97MSelling, General & Admin$10.77MResearch & Development$32.16MInterest Expense$41.00KRevenue$1.50M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

LPTX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
70.06M87.04M56.76M42.93M30.04M
57.21M73.23M44.97M32.16M20.42M
12.85M13.81M11.80M10.77M9.62M
-70.06M-87.04M-56.76M-41.43M-28.54M
585.00K0147.00K-24.00K-2.00K
-67.56M-81.41M-54.60M-40.59M-27.51M
-67.79M-81.41M-54.60M-40.59M-37.59M
-67.79M-81.41M-54.60M-40.59M-37.59M
-67.56M-81.41M-54.60M-40.59M-27.51M
-1.81-3.98-4.82-4.70-6.30
-1.81-3.98-4.82-4.70-6.30
-1.81-3.98-4.82-4.70-6.30
-66.97M-81.41M-54.40M-40.57M-27.48M
-66.97M-81.41M-54.40M-40.57M-27.48M
234.00K00010.07M
37.55M20.45M11.32M8.58M5.93M
37.55M20.45M11.32M8.58M5.93M